Sort
40,608 grants matching “prostate cancer”
Confocal Core for the Laboratory of Cellular and Molecular Biology
$646,597Valarie Barr · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Stimulation of Tumorigenesis by NKG2D
$646,415Thomas Spies · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Stimulation of Tumorigenesis by NKG2D
$646,415Thomas Spies · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development
$646,360Owen N Witte · University Of California Los Angeles · R01 · FY2018 · CA
Determining the clinical impact of gene expression testing in localized prostate cancer
$646,294Todd M. Morgan · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Hormones and Cytokines in CaP risk and recurrence
$646,260Brigham And Women'S Hospital · R01 · FY2004 · CA
RCT of an Online Multimedia Program to Boost Coping & Function for Pca Survivors
$646,116Suzanne M Miller · Research Inst Of Fox Chase Can Ctr · R01 · FY2014 · CA
Focal Laser Ablation of Prostate Cancer using MR/US Fusion
$646,102Leonard Stephen Marks · University Of California Los Angeles · R01 · FY2020 · CA
Identification of DNA methylation markers for risk of metastasis in localized pro
$646,064Chun R. Chao · Kaiser Foundation Research Institute · R01 · FY2019 · CA
Highly selective targeted theranostics for prostate cancers
$645,854James Peter Basilion · Case Western Reserve University · R01 · FY2022 · CA
Mechanisms of resistance to Androgen Receptor inhibition in prostate cancer
$645,742David Vanderweele · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
$645,626Brian E Henderson · University Of Southern California · U01 · FY2009 · CA
Integrated omics analysis of clonal hematopoiesis and cardiovascular disease risk in TOPMed
$645,578Karen Conneely · Emory University · R01 · FY2025 · HL
Variation in tumor-associated immune profiles and colorectal cancer outcomes
$645,534Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · CA
"DNMT and TET1 reprogramming as a targetable mechanism of resistance in advanced prostate cancer"
$645,518David S. Rickman · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Transgenic Core Facility
$645,461Deborah Swing · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer
$645,460William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
3D High Resolution Magnetic Resonance Fingerprinting for Prostate Cancer
$645,406Yun Jiang · University Of Michigan At Ann Arbor · R37 · FY2025 · CA
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
$645,363Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes
$644,974Stephen Jay Freedland · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Control of Protein Translation in Cancer Pathogenesis
$644,970Pier Paolo Pandolfi · Sloan-Kettering Inst Can Research · U01 · FY2007 · CA
Defining the Mechanistic Basis of Bacterial Androgen Production in Dampening Anti-Tumor Immunity and Promoting Resistance to Androgen Receptor Axis-Targeted Therapies for Metastatic Prostate Cancer
$644,763Karen Sandell Sfanos · Johns Hopkins University · R01 · FY2025 · CA
Multi-Modality Quantitative Imaging for Evaluation of Response to Cancer Therapy
$644,667Michael A Jacobs · Johns Hopkins University · U01 · FY2019 · CA
MINIMALLY INVASIVE ASSESSMENTS OF PROSTATE CANCER MOLECULAR HETEROGENEITY TO DIRECT PRECISION THERAPY
$644,653Fred Hutchinson Cancer Research Center · · FY2015 · Department of Defense
Magneto-Nano Protein Chip and Multiplex Sorter for Monitoring Tumor Markers
$644,650Shan X. Wang · Stanford University · U54 · FY2007 · CA